Sai Life Sciences IPO includes a fresh issue of 1.73 Cr shares worth ₹950 Cr and an OFS of 3.81 Cr shares worth ₹2,092.62 Cr to repay debt and for corporate purposes.
Open Date : December 11, 2024 Close Date :December 13, 2024 Allotment Date: December 16, 2024 Listing Date: December 18, 2024
IPO Price: INR 522-549 per share Lot Size: 27 Shares Total Issue Size: INR 3,042.62 crores
Sai Life Sciences IPO shows mixed performance: 1. Revenue: Steady growth. 2. Equity & Profitability: Increased. 3. EPS & RoNW: Improved. 4. Assets: Growth observed. 5. Outlook: Strong financial growth and expansion potential.
Sai Life Sciences IPO Comparison: 1. Companies: Sai Life Sciences,Divi’s Laboratories, Suven Pharmaceuticals, Syngene International. 2. Performance: Varying market cap, profitability, and earnings. 3. Sector: Strengths in pharma and biotech.
Objective: Repay or prepay outstanding borrowings.
Sai Life Sciences IPO Risks: 1. Risks: Dependence on funding, customer audits, regulatory challenges. 2. Impact: Discontinuations or contract terminations could affect performance and reputation.